Clinicopathologic characterization of secretory carcinoma of salivary gland.
Mammary analog secretory carcinoma
Salivary gland tumor
Secretory carcinoma
Journal
World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544
Informations de publication
Date de publication:
25 Oct 2024
25 Oct 2024
Historique:
received:
29
07
2024
accepted:
16
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
To investigate the clinicopathologic characteristics, therapeutic methods, and prognosis of secretory carcinoma of salivary gland (SCSG). The clinicopathologic data of 13 patients with SCSG admitted to Shanxi Cancer Hospital from January 2018 to June 2023 were retrospectively analyzed, and a literature review was performed. A total of eight males and five females aged 22-78 years old were enrolled, and they commonly presented with painless masses in the parotid or submandibular gland. They all underwent surgical treatment, accompanied by typical pathological examinations postoperatively. Fluorescence in situ hybridization (FISH) was conducted in seven cases, the results were all positive, and no gene fusion other than ETV6-NTRK3 was found. Two patients developed local relapse during follow-up, both of which were in the surgical area. By the end of the follow-up, 12 patients survived and one patient died. SCSG is a rare low-grade malignancy with a good prognosis. Pathological and immunohistochemical characteristics are the key to secretory carcinoma (SC) diagnosis, and surgical excision is the major treatment means for SCSG. Whether to perform simultaneous cervical lymph node dissection and other adjuvant therapies should be determined based on the pathological stage and the presence or absence of high-risk factors.
Sections du résumé
BACKGROUND
BACKGROUND
To investigate the clinicopathologic characteristics, therapeutic methods, and prognosis of secretory carcinoma of salivary gland (SCSG).
METHODS
METHODS
The clinicopathologic data of 13 patients with SCSG admitted to Shanxi Cancer Hospital from January 2018 to June 2023 were retrospectively analyzed, and a literature review was performed.
RESULTS
RESULTS
A total of eight males and five females aged 22-78 years old were enrolled, and they commonly presented with painless masses in the parotid or submandibular gland. They all underwent surgical treatment, accompanied by typical pathological examinations postoperatively. Fluorescence in situ hybridization (FISH) was conducted in seven cases, the results were all positive, and no gene fusion other than ETV6-NTRK3 was found. Two patients developed local relapse during follow-up, both of which were in the surgical area. By the end of the follow-up, 12 patients survived and one patient died.
CONCLUSIONS
CONCLUSIONS
SCSG is a rare low-grade malignancy with a good prognosis. Pathological and immunohistochemical characteristics are the key to secretory carcinoma (SC) diagnosis, and surgical excision is the major treatment means for SCSG. Whether to perform simultaneous cervical lymph node dissection and other adjuvant therapies should be determined based on the pathological stage and the presence or absence of high-risk factors.
Identifiants
pubmed: 39456022
doi: 10.1186/s12957-024-03561-9
pii: 10.1186/s12957-024-03561-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
282Informations de copyright
© 2024. The Author(s).
Références
Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599–608.
pubmed: 20410810
doi: 10.1097/PAS.0b013e3181d9efcc
Seethala RR, Stenman G. Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55–67.
pubmed: 28247227
pmcid: 5340736
doi: 10.1007/s12105-017-0795-0
Sun J, Liu S, Fu K, et al. Clinicopathological characteristics and outcomes of 23 patients with secretory carcinoma of major salivary glands. Sci Rep. 2021;11(1):22639.
pubmed: 34811395
pmcid: 8609010
doi: 10.1038/s41598-021-01970-4
Suzuki K, Harada H, Takeda M, et al. Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report. BMC Med Genomics. 2022;15(1):6.
pubmed: 34991563
pmcid: 8739673
doi: 10.1186/s12920-022-01155-6
Skálová A, Hyrcza MD, Leivo I. Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands. Head Neck Pathol. 2022;16(1):40–53.
pubmed: 35312980
pmcid: 9018948
doi: 10.1007/s12105-022-01420-1
Forsythe A, Zhang W, Phillip Strauss U, et al. A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors. Ther Adv Med Oncol. 2020;12:1758835920975613.
pubmed: 33425024
pmcid: 7758559
doi: 10.1177/1758835920975613
Miesbauerová M, Tommola S, Šteiner P, et al. Cytopathological features of secretory carcinoma of salivary glands and ancillary techniques in its diagnostics: impact of new Milan system for reporting salivary gland cytopathology. Apmis. 2019;127(7):491–502.
pubmed: 30942913
doi: 10.1111/apm.12950
Boliere C, Murphy J, Qaisi M, et al. Mammary analogue secretory carcinoma of the palate: case report and review of the literature. Case Rep Dent. 2019;2019:7416302.
pubmed: 30937197
pmcid: 6415289
Mossinelli C, Pigni C, Sovardi F, et al. Synchronous parotid (Mammary analog) secretory carcinoma and acinic cell carcinoma: report of a case. Head Neck Pathol. 2019;13(4):686–91.
pubmed: 29876739
doi: 10.1007/s12105-018-0935-1
Jackson BS, Pratt TL, Van Rooyen A. Mammary analogue secretory carcinoma: a rare salivary gland tumour. S Afr Med J. 2017;107(4):304–6.
pubmed: 28395680
doi: 10.7196/SAMJ.2017.v107i4.12228
Min FH, Li J, Tao BQ, et al. Parotid mammary analogue secretory carcinoma: a case report and review of literature. World J Clin Cases. 2021;9(16):4052–62.
pubmed: 34141766
pmcid: 8180236
doi: 10.12998/wjcc.v9.i16.4052
Ngouajio AL, Drejet SM, Phillips DR, et al. A systematic review including an additional pediatric case report: pediatric cases of mammary analogue secretory carcinoma. Int J Pediatr Otorhinolaryngol. 2017;100:187–93.
pubmed: 28802370
doi: 10.1016/j.ijporl.2017.07.004
Salgado CM, Alaggio R, Reyes-Múgica M, et al. Clinicopathologic and molecular characterization of four cases of pediatric salivary secretory carcinoma (SSC), one with ETV6-RET fusion. Head Neck Pathol. 2021;15(3):796–802.
pubmed: 33459993
pmcid: 8385095
doi: 10.1007/s12105-021-01288-7
Baněčková M, Thompson LDR, Hyrcza MD, et al. Salivary gland secretory carcinoma: clinicopathologic and genetic characteristics of 215 cases and proposal for a grading system. Am J Surg Pathol. 2023;47(6):661–77.
pubmed: 37070739
doi: 10.1097/PAS.0000000000002043
Xu B, Viswanathan K, Umrau K, et al. Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors. Histopathology. 2022;81(5):670–9.
pubmed: 35974431
pmcid: 9580072
doi: 10.1111/his.14772
Wiles AB, Gabrielson M, Baloch ZW, et al. Secretory carcinoma of the salivary gland, a rare entity: an international multi-institutional study. Cancer Cytopathol. 2022;130(9):684–94.
pubmed: 35385604
pmcid: 9545582
doi: 10.1002/cncy.22574
Serrano-Meneses GJ, Brenes Guzmán S, Serrano-Meneses MA, et al. Insights into pediatric secretory carcinoma of the salivary gland: a case report. Cureus. 2024;16(5):e60355.
pubmed: 38883019
pmcid: 11178125
de Lima-Souza RA, Ferreira IV, Chone CT, et al. Secretory carcinoma of the minor salivary gland: an in-depth case report. Oral Oncol. 2024;158:107005.
pubmed: 39178507
doi: 10.1016/j.oraloncology.2024.107005
Sakhariya SV, Chincholkar A, Tidke S, et al. Unmasking the rarity of mammary analogue secretory carcinoma of the minor salivary gland - a case report. Int J Surg case Rep. 2024;124:110374.
pubmed: 39357481
pmcid: 11471663
doi: 10.1016/j.ijscr.2024.110374
Chu YH, Kobrossy B, Schwartz D, et al. Secretory carcinoma of the thyroid: a case report and update of literature. Head Neck Pathol. 2024;18(1):84.
pubmed: 39306639
doi: 10.1007/s12105-024-01693-8
Mahomed F, de Bruin J, Ngwenya S, et al. ETV6 molecular heterogeneity in salivary secretory carcinoma: a case series report and literature review. Head Neck Pathol. 2024;18(1):66.
pubmed: 39101978
pmcid: 11300731
doi: 10.1007/s12105-024-01673-y
Duraisamy KG, C S. Non indigenous mammary secretory carcinoma of parotid gland - an unusual presentation. Indian J Otolaryngol head neck Surgery: Official Publication Association Otolaryngologists India. 2024;76(3):2859–68.
doi: 10.1007/s12070-024-04540-y
Mokhles P, Sadeghipour A, Babaheidarian P, et al. Salivary gland secretory carcinoma presenting as a cervical soft tissue mass: a case report. J Med Case Rep. 2024;18(1):78.
pubmed: 38311786
pmcid: 10840246
doi: 10.1186/s13256-024-04364-y
Wang T, Yang X, Yao L, et al. Clinicopathological analysis of 18 cases of secretory carcinoma of the salivary glands. J Dent Sci. 2024;19(1):109–17.
pubmed: 38303791
doi: 10.1016/j.jds.2023.05.023
Patel A, LaBarge B, King TS, et al. Defining the clinical characteristics of mammary analog secretory carcinoma of the salivary gland: analysis of the national cancer database. SAGE open Med. 2023;11:20503121231200103.
pubmed: 37767536
pmcid: 10521276
doi: 10.1177/20503121231200103
Moriyama E, Nagasu S, Tanaka T, et al. Case report: a case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer. Front Oncol. 2023;13:1247435.
pubmed: 37601665
pmcid: 10436465
doi: 10.3389/fonc.2023.1247435
Langah NA, Ahad A, Ghaloo SK, et al. Secretory carcinoma of minor salivary glands of buccal mucosa: a case report and review of the literature. Int J Surg case Rep. 2023;107:108357.
pubmed: 37276758
pmcid: 10258499
doi: 10.1016/j.ijscr.2023.108357
Bhandarkar AM, Menon A, Geetha V, et al. Mammary analogue secretory carcinoma of parotid - a pathological mystery. Indian J Otolaryngol head neck Surgery: Official Publication Association Otolaryngologists India. 2023;75(2):905–8.
doi: 10.1007/s12070-022-03142-w
Ash J, Mallick S, Vogiatzis P, et al. Secretory carcinoma in the parotid gland of a pediatric patient. A challenging diagnosis. J oral Maxillofacial Pathology: JOMFP. 2023;27(2):420–3.
pubmed: 37854914
pmcid: 10581304
doi: 10.4103/jomfp.jomfp_461_22
Avondet L, Adan R, Berenstein BM, et al. Mammary analogue secretory carcinoma of the salivary glands. Ecancermedicalscience. 2023;17:1511.
pubmed: 37113723
pmcid: 10129378
doi: 10.3332/ecancer.2023.1511
Lassche G, van Engen-van Grunsven ACH, van Hooij O, et al. Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors. Oral Oncol. 2023;137:106297.
pubmed: 36610231
doi: 10.1016/j.oraloncology.2022.106297
Yue C, Zhao X, Ma D, et al. Secretory carcinoma of the sinonasal cavity and pharynx: a retrospective analysis of four cases and literature review. Annals Diagn Pathol. 2022;61:152052.
doi: 10.1016/j.anndiagpath.2022.152052
Saliba M, Mohanty AS, Ho AL, et al. Secretory carcinoma of the thyroid in a 49-year-old man treated with larotrectinib: protracted clinical course of disease despite the high-grade histologic features. Head Neck Pathol. 2022;16(2):612–20.
pubmed: 34655408
doi: 10.1007/s12105-021-01386-6
Yassin-Kassab A, Gainor D, Sufyan AS. Atypical presentation of mammary analogue secretory carcinoma of the lip. Ear Nose Throat J. 2022;101(5):Np212–7.
Ogawa M, Yokoo S, Yamaguchi T, et al. Diagnosis and treatment of secretory carcinoma arising from the oral minor salivary gland: two case reports. Medicine. 2021;100(51):e28390.
pubmed: 34941172
doi: 10.1097/MD.0000000000028390
Agaimy A, Baněčková M, Ihrler S, et al. ALK rearrangements characterize 2 distinct types of salivary gland carcinomas: clinicopathologic and molecular analysis of 4 cases and literature review. Am J Surg Pathol. 2021;45(9):1166–78.
pubmed: 33871952
doi: 10.1097/PAS.0000000000001698
Venkat S, Fitzpatrick S, Drew PA, et al. Secretory carcinoma of the oral cavity: a retrospective case series with review of literature. Head Neck Pathol. 2021;15(3):893–904.
pubmed: 33660147
doi: 10.1007/s12105-021-01310-y
Vasanthi V, Ramadoss R. Secretory carcinoma of salivary gland - a systematic review of pediatric case reports and case series. J oral Maxillofacial Pathology: JOMFP. 2021;25(2):327–31.
pubmed: 34703129
doi: 10.4103/0973-029X.325236
Owosho AA, Tyler D, Summersgill KF. A clinicopathologic study of secretory carcinoma of minor salivary gland: a series of 4 cases and diagnostic considerations. Oral Surg oral Med oral Pathol oral Radiol. 2021;131(4):463–7.
pubmed: 32493684
doi: 10.1016/j.oooo.2020.04.001
Nakaguro M, Faquin WC, Baloch ZW, et al. Fine needle aspiration of salivary gland carcinomas with high-grade transformation: a multi-institutional study of 22 cases and review of the literature. Cancer Cytopathol. 2021;129(4):318–25.
pubmed: 33211402
doi: 10.1002/cncy.22388
Terada T, Kawata R, Noro K, et al. Clinical characteristics of acinic cell carcinoma and secretory carcinoma of the parotid gland. Eur Arch Otorhinolaryngol. 2019;276(12):3461–6.
pubmed: 31440815
doi: 10.1007/s00405-019-05604-4
Tokuzen N, Goda H, Nakashiro K. Locally advanced mammary analogue secretory carcinoma of the parotid gland. Int J Oral Maxillofac Surg. 2019;48(7):865–8.
pubmed: 30777712
doi: 10.1016/j.ijom.2019.01.027
Black M, Liu CZ, Onozato M, et al. Concurrent identification of novel EGFR-SEPT14 fusion and ETV6-RET fusion in secretory carcinoma of the salivary gland. Head Neck Pathol. 2020;14(3):817–21.
pubmed: 31502214
doi: 10.1007/s12105-019-01074-6
Kim SH, Hong ME, Lee DJ. A case of mammary analogue secretory carcinoma of the parotid gland: a case report. Med (Baltim). 2020;99(28):e20218.
doi: 10.1097/MD.0000000000020218
Guilmette J, Nielsen GP, Faquin WC, et al. Ultrastructural characterization of mammary analogue secretory carcinoma of the salivary glands: a distinct entity from acinic cell carcinoma? Head Neck Pathol. 2017;11(4):419–26.
pubmed: 28194567
pmcid: 5677066
doi: 10.1007/s12105-017-0784-3
Hong DS, DuBois SG, Kummar S, et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. Lancet Oncol. 2020;21(4):531–40.
pubmed: 32105622
pmcid: 7497841
doi: 10.1016/S1470-2045(19)30856-3
Khurram SA, Speight PM. Characterisation of DOG-1 expression in salivary gland tumours and comparison with myoepithelial markers. Head Neck Pathol. 2019;13(2):140–8.
pubmed: 29671211
doi: 10.1007/s12105-018-0917-3
Taverna C, Baněčková M, Lorenzon M, et al. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics. Histopathology. 2021;79(3):315–24.
pubmed: 32931030
doi: 10.1111/his.14251
Wu B, Loh TKS, Vanecek T, et al. (Mammary analogue) Secretory carcinoma of the nasal cavity: report of a rare case with p63 and DOG1 expression and uncommon exon 4-Exon 14 ETV6-NTRK3 Fusion diagnosed with next generation sequencing. Head Neck Pathol. 2020;14(2):542–9.
pubmed: 31273600
doi: 10.1007/s12105-019-01051-z
Pang Y, Sun L, Liu H, et al. Differential diagnosis and treatment of salivary secretory carcinoma and acinic cell carcinoma. Oral Oncol. 2021;119:105370.
pubmed: 34157553
doi: 10.1016/j.oraloncology.2021.105370
Hamamoto Y, Harada H, Kohara M, et al. Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland. Med Mol Morphol. 2021;54(1):23–30.
pubmed: 32488412
doi: 10.1007/s00795-020-00256-4
Paudel D, Nishimura M, Adhikari BR, et al. Secretory carcinoma of minor salivary gland in buccal mucosa: a case report and review of the literature. Case Rep Pathol. 2019;2019:2074504.
pubmed: 31032132
pmcid: 6457284
Skalova A, Leivo I, Hellquist H, et al. High-grade transformation/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance. Adv Anat Pathol. 2021;28(3):107–18.
pubmed: 33825717
doi: 10.1097/PAP.0000000000000298
Skálová A, Banečkova M, Thompson LDR, et al. Expanding the molecular spectrum of secretory carcinoma of salivary glands with a novel VIM-RET fusion. Am J Surg Pathol. 2020;44(10):1295–307.
pubmed: 32675658
doi: 10.1097/PAS.0000000000001535
Xu B, Aryeequaye R, Wang L, et al. Sinonasal secretory carcinoma of salivary gland with high grade transformation: a case report of this under-recognized diagnostic entity with prognostic and therapeutic implications. Head Neck Pathol. 2018;12(2):274–8.
pubmed: 28980201
doi: 10.1007/s12105-017-0855-5
Sharma P, Sivakumar N, Pandiar D. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review. J Oral Pathol Med. 2023;52(3):255–62.
pubmed: 36207812
doi: 10.1111/jop.13373
Gatalica Z, Xiu J, Swensen J, et al. Molecular characterization of cancers with NTRK gene fusions. Mod Pathol. 2019;32(1):147–53.
pubmed: 30171197
doi: 10.1038/s41379-018-0118-3
Skalova A, Vanecek T, Martinek P, et al. Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol. 2018;42(2):234–46.
pubmed: 29076873
doi: 10.1097/PAS.0000000000000972
Rooper LM, Karantanos T, Ning Y, et al. Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity. Am J Surg Pathol. 2018;42(8):1121–6.
pubmed: 29683815
doi: 10.1097/PAS.0000000000001065
Guilmette J, Dias-Santagata D, Nosé V, et al. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol. 2019;83:50–8.
pubmed: 30130630
doi: 10.1016/j.humpath.2018.08.011
Pfister DG, Spencer S, Adelstein D, et al. Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(7):873–98.
pubmed: 32634781
doi: 10.6004/jnccn.2020.0031
Ayre G, Hyrcza M, Wu J, et al. Secretory carcinoma of the major salivary gland: Provincial population-based analysis of clinical behavior and outcomes. Head Neck. 2019;41(5):1227–36.
pubmed: 30592355
doi: 10.1002/hed.25536
Sun L, Thorson T, Zhu R, et al. A case report of parotid mammary analogue secretory carcinoma and reviews. Int J Surg Case Rep. 2019;55:88–91.
pubmed: 30716709
pmcid: 6360266
doi: 10.1016/j.ijscr.2019.01.004
Anderson JL, Haidar YM, Armstrong WB, et al. Analysis of clinical features of Mammary Analog Secretory Carcinoma using the Surveillance, Epidemiology, and end results database. JAMA Otolaryngol Head Neck Surg. 2019;145(1):91–3.
pubmed: 30419133
doi: 10.1001/jamaoto.2018.2936
Martínez R, Marín C, Niklander S, et al. Exophytic swelling of the buccal mucosa in a young female patient. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(4):267–71.
pubmed: 29551257
doi: 10.1016/j.oooo.2018.02.007
Cai Y, Cai F, Qiao H, et al. The significance of the morphological and immunological characteristics in the diagnosis of parotid mammary analogue secretory carcinoma: five case reports and a review of the literature. Int J Clin Exp Pathol. 2019;12(6):2233–40.
pubmed: 31934046
pmcid: 6949610
Drilon A, Laetsch TW, Kummar S, et al. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med. 2018;378(8):731–9.
pubmed: 29466156
pmcid: 5857389
doi: 10.1056/NEJMoa1714448
Cipriani NA, Blair EA, Finkle J, et al. Salivary gland secretory carcinoma with high-grade transformation, CDKN2A/B loss, distant metastasis, and lack of sustained response to crizotinib. Int J Surg Pathol. 2017;25(7):613–8.
pubmed: 28497708
doi: 10.1177/1066896917709350
Alves LDB, de Melo AC, Farinha TA, et al. A systematic review of secretory carcinoma of the salivary gland: where are we? Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;132(4):e143–52.
pubmed: 32493686
doi: 10.1016/j.oooo.2020.04.007